216 related articles for article (PubMed ID: 33517440)
1. Autonomic mechanisms of blood pressure alterations during sleep in orexin/hypocretin-deficient narcoleptic mice.
Alvente S; Berteotti C; Bastianini S; Lo Martire V; Matteoli G; Silvani A; Zoccoli G
Sleep; 2021 Jul; 44(7):. PubMed ID: 33517440
[TBL] [Abstract][Full Text] [Related]
2. Modulation of sympathetic vasoconstriction is critical for the effects of sleep on arterial pressure in mice.
Lo Martire V; Silvani A; Alvente S; Bastianini S; Berteotti C; Valli A; Zoccoli G
J Physiol; 2018 Feb; 596(4):591-608. PubMed ID: 29266348
[TBL] [Abstract][Full Text] [Related]
3. Sleep related changes in blood pressure in hypocretin-deficient narcoleptic mice.
Bastianini S; Silvani A; Berteotti C; Elghozi JL; Franzini C; Lenzi P; Lo Martire V; Zoccoli G
Sleep; 2011 Feb; 34(2):213-8. PubMed ID: 21286242
[TBL] [Abstract][Full Text] [Related]
4. Behavioral state instability in orexin knock-out mice.
Mochizuki T; Crocker A; McCormack S; Yanagisawa M; Sakurai T; Scammell TE
J Neurosci; 2004 Jul; 24(28):6291-300. PubMed ID: 15254084
[TBL] [Abstract][Full Text] [Related]
5. The inappropriate occurrence of rapid eye movement sleep in narcolepsy is not due to a defect in homeostatic regulation of rapid eye movement sleep.
Roman A; Meftah S; Arthaud S; Luppi PH; Peyron C
Sleep; 2018 Jun; 41(6):. PubMed ID: 29522212
[TBL] [Abstract][Full Text] [Related]
6. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes.
Willie JT; Chemelli RM; Sinton CM; Tokita S; Williams SC; Kisanuki YY; Marcus JN; Lee C; Elmquist JK; Kohlmeier KA; Leonard CS; Richardson JA; Hammer RE; Yanagisawa M
Neuron; 2003 Jun; 38(5):715-30. PubMed ID: 12797957
[TBL] [Abstract][Full Text] [Related]
7. Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice.
Nakamura A; Zhang W; Yanagisawa M; Fukuda Y; Kuwaki T
J Appl Physiol (1985); 2007 Jan; 102(1):241-8. PubMed ID: 16959906
[TBL] [Abstract][Full Text] [Related]
8. Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy.
Burlet S; Tyler CJ; Leonard CS
J Neurosci; 2002 Apr; 22(7):2862-72. PubMed ID: 11923451
[TBL] [Abstract][Full Text] [Related]
9. Sex-related differences within sleep-wake dynamics, cataplexy, and EEG fast-delta power in a narcolepsy mouse model.
Piilgaard L; Rose L; Gylling Hviid C; Kohlmeier KA; Kornum BR
Sleep; 2022 Jul; 45(7):. PubMed ID: 35266540
[TBL] [Abstract][Full Text] [Related]
10. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice.
Kantor S; Mochizuki T; Lops SN; Ko B; Clain E; Clark E; Yamamoto M; Scammell TE
Sleep; 2013 Aug; 36(8):1129-38. PubMed ID: 23904672
[TBL] [Abstract][Full Text] [Related]
11. Control of cardiovascular variability during undisturbed wake-sleep behavior in hypocretin-deficient mice.
Silvani A; Bastianini S; Berteotti C; Lo Martire V; Zoccoli G
Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(8):R958-64. PubMed ID: 22357806
[TBL] [Abstract][Full Text] [Related]
12. Orexin neuron-mediated skeletal muscle vasodilation and shift of baroreflex during defense response in mice.
Zhang W; Sakurai T; Fukuda Y; Kuwaki T
Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1654-63. PubMed ID: 16410401
[TBL] [Abstract][Full Text] [Related]
13. TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.
Ishikawa T; Hara H; Kawano A; Tohyama K; Kajita Y; Miyanohana Y; Koike T; Kimura H
J Pharmacol Exp Ther; 2023 Jun; 385(3):193-204. PubMed ID: 37001988
[TBL] [Abstract][Full Text] [Related]
14. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
15. Effect of ambient temperature on sleep breathing phenotype in mice: the role of orexins.
Berteotti C; Lo Martire V; Alvente S; Bastianini S; Matteoli G; Silvani A; Zoccoli G
J Exp Biol; 2020 Jun; 223(Pt 13):. PubMed ID: 32457059
[TBL] [Abstract][Full Text] [Related]
16. Abnormal sleep/wake dynamics in orexin knockout mice.
Diniz Behn CG; Klerman EB; Mochizuki T; Lin SC; Scammell TE
Sleep; 2010 Mar; 33(3):297-306. PubMed ID: 20337187
[TBL] [Abstract][Full Text] [Related]
17. Sleep and cardiovascular phenotype in middle-aged hypocretin-deficient narcoleptic mice.
Silvani A; Bastianini S; Berteotti C; Cenacchi G; Leone O; Lo Martire V; Papa V; Zoccoli G
J Sleep Res; 2014 Feb; 23(1):98-106. PubMed ID: 24033681
[TBL] [Abstract][Full Text] [Related]
18. Specificity of direct transition from wake to REM sleep in orexin/ataxin-3 transgenic narcoleptic mice.
Fujiki N; Cheng T; Yoshino F; Nishino S
Exp Neurol; 2009 May; 217(1):46-54. PubMed ID: 19416673
[TBL] [Abstract][Full Text] [Related]
19. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive detection of narcolepsy type I phenotypical features and disease progression by continuous home-cage monitoring of activity in two mouse models: the HCRT-KO and DTA model.
Piilgaard L; Rose L; Justinussen JL; Hviid CG; Lemcke R; Wellendorph P; Kornum BR
Sleep; 2023 Sep; 46(9):. PubMed ID: 37210587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
